Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Type 3 5α-reductase is more common and finasteride and dutasteride strongly inhibit it.

Botulinum toxin has potential for treating various skin conditions and improving wound healing.

CYLD mutations cause a variety of skin tumors with symptoms starting around age 16, and treatments are currently limited.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

Excessive hair growth can be assessed by history, exam, and blood tests, and treated with medication like dexamethasone, birth control pills, and spironolactone.

The conclusion is that a new biopsy technique and humidity chamber help study skin mites better and suggest mite overpopulation may cause skin diseases.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

Rutin may help treat symptoms of polycystic ovary syndrome (PCOS) in rats.

Using steroids can increase the risk of heart problems.

Certain hormone treatments can improve acne and related conditions in women.

Combination of 0.25% finasteride and 3% minoxidil works better than just 3% minoxidil for increasing hair thickness in women.

Early diagnosis and treatment of TPP can prevent complications.

Menstrual disorders are common in adolescents and can be influenced by weight, activity, and health issues, requiring careful evaluation and more research for effective treatment.

FPHL common in Taiwanese women; risk factors include BMI, high glucose, early puberty, fewer childbirths, oral contraceptives, and UV exposure.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Antiandrogens can help treat skin conditions like acne and excessive hair in women when used carefully.

Menopause affects hair and skin; more research needed for treatment.

Researchers found genetic mutations causing hypohidrotic ectodermal dysplasia in 88% of studied patients and identified new mutations and genetic variations affecting the disease.

Cetuximab can cause eyelash growth, which is rare but manageable.

Hair loss in elderly women is often caused by various factors, including hormonal changes after menopause.

The document provides advice on how to recognize and treat skin-related side effects of cancer drugs known as EGFR inhibitors.

Blocking the androgen receptor in skin cells reduces their growth response to male hormones, suggesting a possible treatment for skin conditions linked to androgens.

Antiandrogens are effective for conditions like prostate cancer and skin issues, but more research is needed to confirm their benefits and minimize side effects.

Minoxidil may protect nerves and improve hair quality during paclitaxel treatment.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Proteins from stem cells improved hair growth in patients with hair loss.

Future osteoporosis treatments should focus on increasing bone growth, with many promising options available.

Grey hair and baldness may be linked to COVID-19 severity, but more analysis is needed; post-infectious hair loss is related to the severity of the disease and usually recovers within 3-6 months.

Nanotechnology could make hair loss treatments more effective and reduce side effects, but more research is needed before it's available.